mRNA Vaccines Market Analysis and Forecast to 2030 Report

Description

mRNA Vaccines Market Report Highlights:

Key Segments: Non-replicating mRNA, In vivo self-replicating mRNA, CROs, In-house manufacturing, Infectious Disease, Cancer.

Key Companies: AstraZeneca, Pfizer, Sartorius AG, Sanofi, GlaxoSmithKline plc, Lonza Ltd, Emcure Pharmaceuticals.

Geographies: USA, China, UK, Japan, Germany, France, Italy, Spain, The Netherlands, Canada, India, South Korea, Australia, New Zealand, Middle East, Africa, South and Central America

Historical Data: 2018-2020

Forecasting Period: 2021-2030

Research Methods: Primary Research, Secondary Research, COVID-19 Impact Analysis

Forecast Methods: Market Research, Trend Projections, Panel Consensus, Historical Analogy

Pages and Exhibits: 150+ pages, 60+ Statistical Tables, 25+ Analysis Figures

Market Currency: US Dollar ($)

Report Language: English

Report Format: Online, Downloadable PDF, Excel

Available Customizations: Manufacturer Side Report, Distributor Side Report, End-User Side Report, Thought Leadership Report

Market Definition:

mRNA vaccines stimulates potent immunity against infectious diseases such as viral flu, Coronavirus, Zika, Rabis, etc., and also other conditions such as cancer, among others. COIVID-19 pandemic have shifted much attention towards mRNA based vaccines including Pfizer-BioNTech’s Covid vaccine BNT162b2. These vaccines are manufactured in-house or outsourced to contract manufacturing organizations (CMOs).

mRNA Vaccines Market Segmentation:

By Product Type	Non-replicating mRNA In vivo self-replicating mRNA In vitro dendritic cell non-replicating mRNA vaccine
By Manufacturing Type	In-house Manufacturing Contract Manufacturing Organization (CMO)
By Application	Infectious Diseases Cancer HIV Others
mRNA Vaccines Market, by End-User	Hospitals & Clinic Laboratories
mRNA Vaccines Market Major Competitors	AstraZeneca Pfizer Sartorius AG Providence Therapeutics.  Sanofi GlaxoSmithKline plc CureVac N.V.  CanSino Biologics Inc. Moderna, Inc. Lonza Ltd. Emcure Pharmaceuticals Merck & Co., Inc.  Others
mRNA Vaccines Market, By Geography	North America USA Canada South and Central America Europe Germany France K. Italy Spain The Netherlands Rest of Europe Asia-Pacific China Japan India South Korea Australia New-Zealand Rest of Asia-Pacific Middle East & Africa

 

mRNA Vaccines Market Report: Table of Content and Chapter Description:

1. mRNA Vaccines Market Summary

This section includes summary of whole report. It majorly includes brief analysis of market numbers, various forecast factors and market dynamics such as drivers, restraints, opportunities, and key trends. In addition to this, this section also talks about leading players operating in the market.

2. Report Inclusion & Exclusion

This section provides brief idea about the factors included in the study, along with the factors which are not considered in the study. It helps the reader to have better understanding of the provided information.

3. Market Dynamics

This section provides detailed analysis of drivers, restraints, opportunities, and threats which have significant impact on the growth of the market. It also includes key trends influencing the market growth and demand.

4. Key Market Insights

This section majorly includes analysis of micro and macro-economic indicators that would have direct or indirect impact on the market growth. This section also includes pricing analysis, product pipeline analysis, PORTER’S five forces analysis, PESTLE analysis, funding analysis, among others.

5. COVID-19 Impact Analysis

This section provides detailed analysis of pre and post COVID-19 pandemic impact on the market. The section provides effect of COVID-19 during 2020 and 2021, and also provides recovery scenario. In addition to this, it also analyzes impact of vaccination drive on the market recovery.

6. mRNA Vaccines Market Analysis and Forecast to 2030, by Product Type

This section provides detailed country level market estimations and analysis of mRNA Vaccines, by Product Type. The segments majorly include Non-replicating mRNA, In vivo self-replicating mRNA, and In vitro dendritic cell non-replicating mRNA vaccine.

7. mRNA Vaccines Market Analysis and Forecast to 2030, by Manufacturing Type

This report segment includes detailed country level market estimations and forecast for various Manufacturing Type. The segments includes analysis of In-house manufacturing, and Contract manufacturing organizations (CMOs).

8. mRNA Vaccines Market Analysis and Forecast to 2030, by Application

This section includes revenue estimation, forecast and detailed analysis of mRNA Vaccines based on Applications at country level. The segments consist of Infectious diseases, Cancer, HIV, and others.

9. mRNA Vaccines Market Analysis and Forecast to 2030, by End-User

This section includes revenue estimation, forecast and detailed analysis of mRNA Vaccines based on End-User at country level. The segments consist of Hospitals and Clinics.

10. Competition Analysis

This section provides detailed analysis of key companies operating in this market. It includes, products/services ranking, market positioning, company competition matrix, impact analysis, market share analysis, and each company’s overviews.

11. Appendix

11.1 mRNA Vaccines Market: Research Methodology

This section includes detailed explanation of various techniques used during market estimation. It majorly involves primary and secondary research. Primary research involves interviews with industry personals and key opinion leaders from respective sectors, while secondary research includes data gathering through internet search, databases such as Bloomberg, FactSet, among others.

In addition to this, the section also involves explanation of data forecast models used during the study.

11.2 Appendix

11.3 Abbreviations

**Note: Table of Content/ Scope of work subject to change as per client requirements and research updates.